Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Flexes Muscle With Conditions On Merck Takeover Of AZ Electronics

This article was originally published in PharmAsia News

Executive Summary

China's influence in multinational mergers and takeover deals was displayed when its commerce ministry approved a $2.6 billion takeover of the U.K.'s AZ Electronics Materials by Merck KGaA.

China's influence in multinational mergers and takeover deals was displayed when its commerce ministry approved a $2.6 billion takeover of the U.K.'s AZ Electronics Materials by Merck KGAA. The company makes specialty chemicals, including those used in the drug-making process, so the government had an increasingly important say in the matter. The government approved the merger, but set conditions, including a notice of any licensing deals signed in China and a ban on requiring Chinese to buy products from both companies. (Click here for more)

"China Approves Merck KgaA's Takeover Of AZ Electronic" - Reuters (4/30/2014)

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC087037

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel